Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program

Cancer

Volumn 119, Issue SUPPL. 15, 2013, Pages 2834-2841

  Nadel, Marion R ^a   Royalty, Janet ^a   Shapiro, Jean A ^a   Joseph, Djenaba ^a   Seeff, Laura C ^a   Lane, Dorothy S ^b   Dwyer, Diane M ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^c MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

colonoscopy; colorectal neoplasms; fecal occult blood; health care; mass screening; quality indicators

Indexed keywords

ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CECAL INTUBATION; CECUM; CLINICAL ASSESSMENT; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; DATA PROCESSING; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; INTESTINE PREPARATION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL SPECIALIST; OCCULT BLOOD TEST; POLYPECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SEX DIFFERENCE; UNITED STATES;

COLONOSCOPY; COLORECTAL NEOPLASMS; FECAL OCCULT BLOOD; HEALTH CARE; MASS SCREENING; QUALITY INDICATORS;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; QUALITY INDICATORS, HEALTH CARE; UNITED STATES;

EID: 84880552259     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28164     Document Type: Article

References (31)

1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993; 328: 1365-1371.
2. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000; 343: 1603-1607.
3. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348: 1472-1477.
4. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O,. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348: 1467-1471.
5. U.S Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendations statement. Ann Intern Med. 2008; 149: 627-637.
6. Levin B, Lieberman DA, McFarland B, et al. American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008; 58: 130-160.
7. Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW,. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med. 2009; 37: 8-16.
8. Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med. 2005; 142: 86-94.
9. Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC,. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med. 2010; 25: 833-839.
10. Collins JF, Lieberman DA, Durbin TE, Weiss DG,; Veterans Affairs Cooperative Study #380 Group. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med. 2005; 142: 81-85.
11. Rex DK, Bond JH, Winawer S, et al. U.S. Multi-Society Task Force on Colorectal Cancer. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2002; 97: 1296-1308.
12. Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006; 63 (suppl 4): S16-S28.
13. Lieberman DA, Faigel DO, Logan JR, et al. Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc. 2009; 69 (3 pt 2): 645-653.
14. Li J, Nadel MR, Poppell CF, Dwyer DM, Lieberman DA, Steinberger EK,. Quality assessment of colonoscopy reporting: results from a statewide cancer screening program [published online ahead of print September 28, 2010]. Diagn Ther Endosc. 2010;2010. pii: 419796. doi: 10.1155/2010/419796.
15. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF,. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004; 141: 264-271.
16. Schoen RE, Pinsky PF, Weissfeld JL, et al. Utilization of surveillance colonoscopy in community practice. Gastroenterology. 2010; 138: 73-81.
17. Seeff LC, DeGroff A, Tangka F, et al. Development of a federally funded demonstration colorectal cancer screening program. Prev Chronic Dis. 2008; 5: A64.
18. Seeff LC, Royalty J, Helsel WE, et al. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (suppl 15): 2820-2833.
19. Winawer S, Zauber AG, Fletcher RH, et al. US Multi-Society Task Force on Colorectal Cancer; American Cancer Society. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006; 130: 1872-1885.
20. Fletcher RH, Nadel MR, Allen JI, et al. The quality of colonoscopy services-responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med. 2010; 25: 1230-1234.
21. Lieberman D, Nadel M, Smith RA, et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007; 65: 757-766.
22. Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW,. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1623-1630.
23. Phillips KA, Liang SY, Ladabaum U, et al. Trends in colonoscopy for colorectal cancer screening. Med Care. 2007; 45: 160-167.
24. Cotton PB, Connor P, McGee D, et al. Colonoscopy: practice variation among 69 hospital-based endoscopists. Gastrointest Endosc. 2003; 57: 352-357.
25. Bowles CJ, Leicester R, Romaya C, Swarbrick E, Williams CB, Epstein O,. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut. 2004; 53: 277-283.
26. Shah HA, Paszat LF, Saskin R, Stukel TA, Rabeneck L,. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology. 2007; 132: 2297-2303.
27. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010; 362: 1795-1803.
28. National Health Service Bowel Cancer Screening Programme. Quality Assurance Guidelines for Colonoscopy. NHS BCSP Pub. No. 6. Sheffield, UK: National Health Service Cancer Screening Programmes; 2011.
29. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR,. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143: 844-857.
30. Levin TR,. Dealing with uncertainty: surveillance colonoscopy after polypectomy. Am J Gastroenterol. 2007; 102: 1745-1747.
31. Lane DS, Messina CR, Cavanagh MF, Anderson JC,. Delivering colonoscopy screening for low-income populations in Suffolk County: strategies, outcomes, and benchmarks. Cancer. 2013; 119 (suppl 15): 2842-2848.